Artisan Partners Limited Partnership Akero Therapeutics, Inc. Transaction History

Artisan Partners Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$11.38 - $50.33 $80,980 - $358,148	-7,116 Reduced 2.29%	303,920 $7.1 Million
Q3 2023 Nov 09, 2023	BUY	$41.19 - $52.25 $3.03 Million - $3.84 Million	73,452 Added 30.92%	311,036 $15.7 Million
Q2 2023 Aug 10, 2023	SELL	$36.89 - $56.88 $10,292 - $15,869	-279 Reduced 0.12%	237,584 $11.1 Million
Q1 2023 May 11, 2023	SELL	$37.27 - $50.24 $22,436 - $30,244	-602 Reduced 0.25%	237,863 $9.1 Million
Q4 2022 Feb 10, 2023	BUY	$33.44 - $54.8 $7.97 Million - $13.1 Million	238,465 New	238,465 $13.1 Million

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.